Based on this YouTube video's total view count of 224K views and industry-standard rates, the estimated total earning is $157 - $449 through ad revenue. Historical data is not yet available to calculate daily, weekly, or monthly averages.

Explore Compared vaccine adverse effects with 224,612 views, 6,641 likes, and 2,029 comments. Experience the impact of this video content that has captured audience attention.

India https://www.mohfw.gov.in Cases, + 216,850 Deaths, + 1,183 = 174,308 Vaccinations, 117,223,509 https://www.bbc.co.uk/news/av/world-asia-india-56747867 Infection drivers Workplaces Markets and malls have reopened Transport operating at full capacity Big weddings Festivals Election rallies Probable new variants Israel Population 9.3 million US and UK vaccination rates UK, 48% of overall population I guess the difference won't bother most news consumers much but I'd like to think your viewers might be more discerning, (Tony) Cerebral venous thrombosis: a retrospective cohort study of 513,284 confirmed COVID -19 cases and a comparison with 489,871 people receiving a COVID -19 mRNA vaccine Can help contextualize the risks and benefits of vaccination in this regard https://www.ox.ac.uk/news/2021-04-15-risk-rare-blood-clotting-higher-covid-19-vaccines https://osf.io/a9jdq/ Using an electronic health records network Absolute incidence of cerebral venous thrombosis (CVT) in the two weeks following: (Incidence of portal vein thrombosis, PVT also assessed) COVID-19 diagnosis (N=513,284) Influenza (N=172,742) Receipt of the BNT162b2 (Pfizer) or mRNA-1273 (Moderna) COVID-19 vaccines (N=489,871) The incidence of CVT after COVID-19 diagnosis CVT = 39.0 per million people The incidence of CVT after influenza diagnosis CVT = Zero per million people Incidence of CVT after receiving BNT162b2 or mRNA-1273 vaccine CVT = 4.1 per million people The incidence of PVT after COVID-19 diagnosis PVT = 436 The incidence of PVT after influenza diagnosis PVT = 98 Incidence of PVT after receiving BNT162b2 or mRNA-1273 vaccine PVT = 44 per million CVT incidence observed across the entire health records network 0.41 per million people over any 2-week period Laboratory test results, available in a subset of the COVID-19 patients, suggestive of: Raised D-dimer, lowered fibrinogen, and an increased rate of thrombocytopenia in the CVT and PVT groups CVT Mortality = 20% in 2 weeks after CoViD PVT mortality = 18.8% in 2 weeks after CoViD Latest estimate from the European Medicines Agency Incidence associated with ChAdOx1 nCoV-19 vaccine CVT = 5.0 per million people Splanchnic thrombosis by the EMA following vaccination with ChAdOx1 (portal, splenic, mesenteric) 53 cases out of 34 million people 1.6 per million people

With SocialCounts.org’s view counter, track your YouTube video’s live view count and YouTube likes count in real time with fast, reliable updates.

Watch every YouTube video live view count rise with our real-time YouTube views tracker—built for accuracy and minimal delay.

Follow YouTube real time views as they happen, using our dedicated view counter for YouTube videos.

Get up-to-date live view count on YouTube and see real-time growth with SocialCounts.org’s smart tracking tools.